Vespera is a high-CBD, low-THC indica strain with strong black pepper, pine and musky aromas that make it instantly distinguishable from other strains and is defined by its medium green and orange colours. While THC is known for the intoxicating effects of cannabis, CBD is non-intoxicating at medically relevant doses. Because Vespera is high in CBD and low in THC, consumption of this dried flower is less likely to produce the “high” or euphoric feeling often associated with high THC cannabis products.
In our recently published patient-reported outcome study, high CBD products were selected as being the most helpful in treating recurrent pain, anxiety and arthritis and other rheumatic disorders1
Remember to follow Health Canada’s guideline of “Starting low and going slow” where patients should begin with a low dose, then wait 30 minutes to assess the effects before administering an additional dose.
Reference: 1. Cahill SP, Lunn SE, Diaz P and Page JE (2021) Evaluation of Patient Reported Safety and Efficacy of Cannabis from a Survey of Medical Cannabis Patients in Canada. Front. Public Health 9:626853.
You have reached your maximum and cannot add this item.
You have reached your order allowance limit for this product.
You have reached your maximum
You can not add anymore of this product
Your prescription has expired
Unfortunately, the THC or CBD of this product is outside your prescription limits. Please choose another product.
Your medical document has been exhausted
Please speak to your health care provider to get a prescription to be able to purchase this product.
These are the most prevalent terpenes in this product. You can learn more about terpenes here.
All of our cannabis products are lab tested to ensure we’re bringing our patients the best quality products possible. Our lab reports are temporarily unavailable on this site while we make enhancements to our systems but rest assured, we continue to follow our rigorous quality assurance and lab testing practices and hope to make these available on the website again in the near future.